Atomistry » Sodium » PDB 6iff-6jbd » 6j3b
Atomistry »
  Sodium »
    PDB 6iff-6jbd »
      6j3b »

Sodium in PDB 6j3b: Crystal Structure of Human Dhodh in Complex with Inhibitor 1289

Enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289

All present enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289:
1.3.5.2;

Protein crystallography data

The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289, PDB code: 6j3b was solved by Y.Yu, Q.Chen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.39 / 1.60
Space group P 32 2 1
Cell size a, b, c (Å), α, β, γ (°) 90.829, 90.829, 122.754, 90.00, 90.00, 120.00
R / Rfree (%) 15.7 / 17.6

Other elements in 6j3b:

The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 also contains other interesting chemical elements:

Fluorine (F) 3 atoms
Chlorine (Cl) 3 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 (pdb code 6j3b). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289, PDB code: 6j3b:
Jump to Sodium binding site number: 1; 2;

Sodium binding site 1 out of 2 in 6j3b

Go back to Sodium Binding Sites List in 6j3b
Sodium binding site 1 out of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na422

b:37.5
occ:1.00
H A:LYS227 2.4 45.0 1.0
OD2 A:ASP267 2.6 18.2 1.0
HA2 A:GLY226 2.6 37.4 1.0
O A:HOH527 2.8 42.0 1.0
N A:LYS227 3.0 37.5 1.0
HB2 A:LYS227 3.2 22.9 1.0
HB2 A:ASP267 3.2 16.5 1.0
HA A:ASP264 3.3 16.1 1.0
CA A:GLY226 3.5 31.1 1.0
CG A:ASP267 3.5 14.4 1.0
HB3 A:ASP267 3.5 16.5 1.0
CB A:ASP267 3.6 13.8 1.0
C A:GLY226 3.7 36.4 1.0
OD1 A:ASP264 3.7 25.1 1.0
HA3 A:GLY226 3.8 37.4 1.0
CB A:LYS227 3.9 19.1 1.0
CA A:LYS227 4.0 26.6 1.0
HG3 A:GLN263 4.2 27.6 1.0
O A:HOH581 4.2 35.9 1.0
HB3 A:LYS227 4.2 22.9 1.0
HA A:LYS227 4.2 31.9 1.0
CA A:ASP264 4.3 13.4 1.0
O A:GLN225 4.4 24.2 1.0
N A:GLY226 4.6 29.9 1.0
OD1 A:ASP267 4.7 16.9 1.0
O A:GLN263 4.7 15.3 1.0
CG A:ASP264 4.7 24.6 1.0
N A:ASP264 4.9 12.9 1.0
O A:GLY226 4.9 28.1 1.0
C A:GLN225 4.9 25.9 1.0
O A:ASP264 4.9 13.9 1.0
CB A:ASP264 5.0 15.7 1.0

Sodium binding site 2 out of 2 in 6j3b

Go back to Sodium Binding Sites List in 6j3b
Sodium binding site 2 out of 2 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1289


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 2 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1289 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na423

b:14.3
occ:1.00
H A:GLY334 2.0 10.1 1.0
H A:VAL336 2.1 9.2 1.0
HA A:LEU355 2.6 10.1 1.0
O2P A:FMN403 2.7 7.2 1.0
HB A:VAL336 2.7 12.1 1.0
O A:GLN354 2.7 8.9 1.0
N A:GLY334 2.8 8.4 1.0
HG23 A:VAL336 2.9 13.2 1.0
N A:VAL336 3.0 7.7 1.0
HG23 A:VAL333 3.1 9.7 0.7
H A:GLY335 3.2 9.0 1.0
N A:GLY335 3.3 7.5 1.0
HA A:VAL333 3.3 12.0 0.7
C A:GLY334 3.3 8.5 1.0
CB A:VAL336 3.4 10.1 1.0
HA A:VAL333 3.4 11.2 0.3
CA A:GLY334 3.4 9.2 1.0
CG2 A:VAL336 3.5 11.0 1.0
CA A:LEU355 3.5 8.4 1.0
HB3 A:LEU355 3.5 12.6 1.0
HA2 A:GLY334 3.6 11.1 1.0
HG13 A:VAL333 3.6 11.3 0.3
P A:FMN403 3.7 9.5 1.0
O5' A:FMN403 3.7 7.0 1.0
HG21 A:VAL336 3.7 13.2 1.0
C A:GLN354 3.7 10.0 1.0
CA A:VAL336 3.7 9.5 1.0
O A:HOH591 3.8 8.7 1.0
HG12 A:VAL333 3.8 11.3 0.3
HG22 A:VAL333 3.8 9.7 0.7
CG2 A:VAL333 3.9 8.1 0.7
C A:VAL333 3.9 8.6 0.7
CB A:LEU355 3.9 10.5 1.0
C A:VAL333 3.9 7.2 0.3
HB2 A:LEU355 3.9 12.6 1.0
O A:GLY334 3.9 8.8 1.0
C A:GLY335 4.0 10.2 1.0
CA A:VAL333 4.0 10.0 0.7
O3P A:FMN403 4.1 8.9 1.0
H A:TYR356 4.1 10.9 1.0
N A:LEU355 4.1 9.7 1.0
CA A:GLY335 4.1 8.0 1.0
CA A:VAL333 4.1 9.3 0.3
CG1 A:VAL333 4.1 9.4 0.3
O A:VAL336 4.3 10.1 1.0
HG22 A:VAL336 4.3 13.2 1.0
HA3 A:GLY334 4.4 11.1 1.0
HE2 A:LYS345 4.4 15.8 1.0
HA2 A:GLY335 4.5 9.6 1.0
CB A:VAL333 4.5 9.3 0.7
HA A:VAL336 4.5 11.4 1.0
C A:VAL336 4.5 11.9 1.0
C A:LEU355 4.6 8.8 1.0
HG21 A:VAL333 4.6 9.7 0.7
N A:TYR356 4.6 9.1 1.0
CG1 A:VAL336 4.7 11.1 1.0
HB A:VAL333 4.8 11.2 0.7
CB A:VAL333 4.8 6.9 0.3
H A:GLN354 4.8 10.3 1.0
C5' A:FMN403 4.9 7.2 1.0
HG11 A:VAL336 4.9 13.3 1.0
H5'1 A:FMN403 4.9 8.6 1.0
HA3 A:GLY335 4.9 9.6 1.0
H A:LEU355 4.9 11.6 1.0
HG11 A:VAL333 5.0 11.3 0.3
HG12 A:VAL336 5.0 13.3 1.0

Reference:

T.Zeng, Z.Zuo, Y.Luo, Y.Zhao, Y.Yu, Q.Chen. A Novel Series of Human Dihydroorotate Dehydrogenase Inhibitors Discovered By in Vitro Screening: Inhibition Activity and Crystallographic Binding Mode. Febs Open Bio V. 9 1348 2019.
ISSN: ESSN 2211-5463
PubMed: 31087527
DOI: 10.1002/2211-5463.12658
Page generated: Tue Oct 8 09:41:25 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy